Stock Performance Spotlight: Pediatrix Medical Group Inc (MD) Ends the Day at 8.34, Down by -0.24

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Pediatrix Medical Group Inc’s stock clocked out at $8.34, down -0.24% from its previous closing price of $8.36. In other words, the price has decreased by -$0.24 from its previous closing price. On the day, 0.64 million shares were traded. MD stock price reached its highest trading level at $8.74 during the session, while it also had its lowest trading level at $8.24.

Ratios:

To gain a deeper understanding of MD’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.63. For the most recent quarter (mrq), Quick Ratio is recorded 1.72 and its Current Ratio is at 1.72. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.87.

On September 27, 2021, SVB Leerink started tracking the stock assigning a Mkt Perform rating and target price of $29.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 14 ’23 when Swift James D sold 5,764 shares for $9.58 per share. The transaction valued at 55,219 led to the insider holds 90,874 shares of the business.

Moore Mary Ann E sold 1,150 shares of MD for $11,063 on Dec 14 ’23. The EVP, General Counsel & Sec now owns 15,730 shares after completing the transaction at $9.62 per share. On Dec 14 ’23, another insider, Moore Mary Ann E, who serves as the EVP, General Counsel & Sec of the company, sold 970 shares for $9.62 each. As a result, the insider received 9,331 and left with 81,385 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 701787648 and an Enterprise Value of 1355317504. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.35 while its Price-to-Book (P/B) ratio in mrq is 0.82. Its current Enterprise Value per Revenue stands at 0.678 whereas that against EBITDA is 7.144.

Stock Price History:

Over the past 52 weeks, MD has reached a high of $15.02, while it has fallen to a 52-week low of $6.62. The 50-Day Moving Average of the stock is 12.26%, while the 200-Day Moving Average is calculated to be -7.06%.

Shares Statistics:

It appears that MD traded 1.35M shares on average per day over the past three months and 582360 shares per day over the past ten days. A total of 84.02M shares are outstanding, with a floating share count of 82.80M. Insiders hold about 1.60% of the company’s shares, while institutions hold 102.26% stake in the company. Shares short for MD as of 1721001600 were 5873040 with a Short Ratio of 4.36, compared to 1718323200 on 7414729. Therefore, it implies a Short% of Shares Outstanding of 5873040 and a Short% of Float of 9.92.

Most Popular